Transfusion-transmitted infections

Although the risk of transfusion-transmitted infections today is lower than ever, the supply of safe blood products remains subject to contamination with known and yet to be identified human pathogens. Only continuous improvement and implementation of donor selection, sensitive screening tests and e...

Full description

Saved in:
Bibliographic Details
Published in:Journal of translational medicine Vol. 5; no. 1; p. 25
Main Authors: Bihl, Florian, Castelli, Damiano, Marincola, Francesco, Dodd, Roger Y, Brander, Christian
Format: Journal Article
Language:English
Published: England BioMed Central Ltd 06.06.2007
BioMed Central
BMC
Subjects:
Bacterial infections
Bacterial Infections - etiology
Bacterial Infections - prevention & control
Blood transfusion
Complications and side effects
Disease Transmission, Infectious - prevention & control
Evaluation
Humans
Patient outcomes
Prion Diseases - etiology
Prion Diseases - prevention & control
Protozoan Infections - etiology
Protozoan Infections - prevention & control
Review
Risk factors
Transfusion Reaction
TT virus infections
Virus Diseases - etiology
Virus Diseases - prevention & control
United States
Switzerland
ISSN:1479-5876, 1479-5876
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Although the risk of transfusion-transmitted infections today is lower than ever, the supply of safe blood products remains subject to contamination with known and yet to be identified human pathogens. Only continuous improvement and implementation of donor selection, sensitive screening tests and effective inactivation procedures can ensure the elimination, or at least reduction, of the risk of acquiring transfusion transmitted infections. In addition, ongoing education and up-to-date information regarding infectious agents that are potentially transmitted via blood components is necessary to promote the reporting of adverse events, an important component of transfusion transmitted disease surveillance. Thus, the collaboration of all parties involved in transfusion medicine, including national haemovigilance systems, is crucial for protecting a secure blood product supply from known and emerging blood-borne pathogens.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1479-5876
1479-5876
DOI:10.1186/1479-5876-5-25